Literature DB >> 17549891

Psychophysiological analysis of the influence of vasopressin on speech in patients with post-stroke aphasias.

Sergei G Tsikunov1, Svetlana G Belokoskova.   

Abstract

Speech is an attribute of the human species. Central speech disorders following stroke are unique models for the investigation of the organization of speech. Achievements in neurobiology suggest that there are possible neuroendocrine mechanisms involved in the organization of speech. It is known that the neuropeptide vasotocin, analogous of vasopressin in mammals, modulates various components of vocalization in animals. Furthermore, the positive influence of vasopressin on memory, which plays an important role in the formation of speech, has been described. In this study, speech organization processes and their recovery with the administration of vasopressin (1-desamino-8-D-arginin-vasopressin) to 26 patients with chronic aphasias after stroke were investigated. Results showed that sub-endocrine doses of the neuropeptide with intranasal administration had positive influence primarily on simple forms of speech and secondarily on composite forms. There were no statistically significant differences between the sensory and integrative components of the organization of speech processes with vasopressin. In all cases, the positive effect of the neuropeptide was demonstrated. As a result of the effects, speech regulated by both brain hemispheres improved. It is suggested that the neuropeptide optimizes the activity both in the left and right hemispheres, with primary influence on the right hemisphere. The persistence of the acquired effects is explained by an induction of compensatory processes resulting in the reorganization of the intra-central connections by vasopressin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17549891     DOI: 10.1017/s1138741600006442

Source DB:  PubMed          Journal:  Span J Psychol        ISSN: 1138-7416            Impact factor:   1.264


  7 in total

1.  Psycholinguistics of Aphasia Pharmacotherapy: Asking the Right Questions.

Authors:  Dalia Cahana-Amitay; Martin L Albert; Abigail Oveis
Journal:  Aphasiology       Date:  2014-01-01       Impact factor: 2.773

Review 2.  Neuroscience insights improve neurorehabilitation of poststroke aphasia.

Authors:  Marcelo L Berthier; Friedemann Pulvermüller
Journal:  Nat Rev Neurol       Date:  2011-02       Impact factor: 42.937

Review 3.  Biological approaches to aphasia treatment.

Authors:  Steven L Small; Daniel A Llano
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 5.081

4.  A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism.

Authors:  Karen J Parker; Ozge Oztan; Robin A Libove; Noreen Mohsin; Debra S Karhson; Raena D Sumiyoshi; Jacqueline E Summers; Kyle E Hinman; Kara S Motonaga; Jennifer M Phillips; Dean S Carson; Lawrence K Fung; Joseph P Garner; Antonio Y Hardan
Journal:  Sci Transl Med       Date:  2019-05-01       Impact factor: 17.956

Review 5.  Drug therapy of post-stroke aphasia: a review of current evidence.

Authors:  Marcelo L Berthier; Friedemann Pulvermüller; Guadalupe Dávila; Natalia García Casares; Antonio Gutiérrez
Journal:  Neuropsychol Rev       Date:  2011-08-16       Impact factor: 7.444

6.  A Review of Biological Interventions in Chronic Aphasia.

Authors:  E Susan Duncan; Aswathy Anakkathil Pradeep; Steven L Small
Journal:  Ann Indian Acad Neurol       Date:  2020-09-25       Impact factor: 1.383

Review 7.  Leveraging a translational research approach to drive diagnostic and treatment advances for autism.

Authors:  Karen J Parker
Journal:  Mol Psychiatry       Date:  2022-04-01       Impact factor: 13.437

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.